Matches in Wikidata for { <http://www.wikidata.org/entity/Q66344131> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66344131 description "clinical trial" @default.
- Q66344131 description "ensayu clínicu" @default.
- Q66344131 description "klinisch onderzoek" @default.
- Q66344131 description "клінічне випробування" @default.
- Q66344131 name "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 name "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 type Item @default.
- Q66344131 label "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 label "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 prefLabel "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 prefLabel "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer" @default.
- Q66344131 P1132 Q66344131-4AFC491A-06F0-4773-82CF-0C0AD4AC8C93 @default.
- Q66344131 P1476 Q66344131-8E86C83C-9202-4D6B-8857-FCDE81EAF634 @default.
- Q66344131 P17 Q66344131-2830E214-A5A3-4F92-B7F0-CD1056E9B8D6 @default.
- Q66344131 P17 Q66344131-45C0D343-1A9B-4137-A0BB-93905E78B379 @default.
- Q66344131 P17 Q66344131-5A885A6F-61BF-4825-B325-441F6F7DB262 @default.
- Q66344131 P17 Q66344131-5E4E0A69-05ED-41A5-8A44-52F631F797E8 @default.
- Q66344131 P17 Q66344131-61DE4670-17BC-428C-815B-AC91A0380AE3 @default.
- Q66344131 P17 Q66344131-B0CF4D40-BBDB-45A7-9E5A-1F7F71E4EA3E @default.
- Q66344131 P17 Q66344131-EE3F7F4F-F823-4665-8145-07A6CEB2E00E @default.
- Q66344131 P2899 Q66344131-02EEC41E-5521-4E07-A7CF-98B293160D96 @default.
- Q66344131 P3098 Q66344131-8048B4FF-B395-4E1C-AE4C-7BD142A3188F @default.
- Q66344131 P31 Q66344131-D8E53E9D-5E08-4FF3-B5F7-764047AA1651 @default.
- Q66344131 P580 Q66344131-7CDC1729-F0E2-45B7-B812-F0789B2E77CC @default.
- Q66344131 P582 Q66344131-03889959-A697-421D-A879-706220556FA2 @default.
- Q66344131 P6099 Q66344131-78A8C9B5-56B2-4E96-B1FA-4112A92CA456 @default.
- Q66344131 P8363 Q66344131-1F31A8DC-511E-4786-B2B0-D0389F438256 @default.
- Q66344131 P1132 "+118" @default.
- Q66344131 P1476 "A PHASE 2, SINGLE-ARM, OPEN-LABEL, MULTICENTER STUDY OF THE CLINICAL ACTIVITY AND SAFETY OF ENZALUTAMIDE IN PATIENTS WITH ADVANCED, ANDROGEN RECEPTOR-POSITIVE, TRIPLE-NEGATIVE BREAST CANCER" @default.
- Q66344131 P17 Q145 @default.
- Q66344131 P17 Q16 @default.
- Q66344131 P17 Q27 @default.
- Q66344131 P17 Q29 @default.
- Q66344131 P17 Q30 @default.
- Q66344131 P17 Q31 @default.
- Q66344131 P17 Q38 @default.
- Q66344131 P2899 "+18" @default.
- Q66344131 P3098 "NCT01889238" @default.
- Q66344131 P31 Q30612 @default.
- Q66344131 P580 "2013-06-01T00:00:00Z" @default.
- Q66344131 P582 "2015-03-01T00:00:00Z" @default.
- Q66344131 P6099 Q42824440 @default.
- Q66344131 P8363 Q78089383 @default.